James Calloway
argenx is seeing further potential for growth around its flagship drug Vyvgart , following encouraging clinical research results in myositi...
read more
Wall & Wire covers markets, earnings and mergers with sharp analysis — TotalEnergies, Berkshire Hathaway, Treasury yields, and more.